BridgeMD
New treatment option for Coronary Disease
Official title Postprocedural Contrast Mediated FFR Plus Intracoronary Infusion of Nitroglycerin in Multivessel Patients (PROMETEUS TRIAL)
ClinicalTrials.gov ID: NCT06273293
What this study is testing
- What it's testing
- the use of pressure wires is the standar of care to evaluate angiographically intermediate coronary lesions, however, limitations in the management of these type of lesions continue to be a challenge for the interventional cardiologist. The use of FFR has some limitations such as the use of adenosine due to its cost, adverse effects (e.g.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients \>18 years old and,
- Patients with multivessel coronary artery disease (multivessel coronary artery disease will be considered the presence of significant stenosis in 2...
- Use of Navvus pressure microcatheter both for functional diagnosis and for post-PCI evaluation of the different vessels and,
- Patients who have signed the Informed Consent.
You likely can't join if
- Patients with intolerance or contraindication to adenosine.
- Hemodynamically unstable patients, acute phase of a STEACS.
- Patient with significant comorbidity with limited life expectancy.
- Patients with the patient's express refusal to participate in the study.
- Pregnant or breastfeeding female patients.
The study team makes the final eligibility decision.
Where it's taking place
- Alicante, Spain
- Badajoz, Spain
- Huelva, Spain
- Seville, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Alicante, Spain; Badajoz, Spain; Huelva, Spain; Seville, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.